Purple Biotech share price logo

Purple Biotech

NASDAQ: PPBT

$1.44

-0.10

(-6.80%)

as on

Purple Biotech Stock Performance

as on September 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.39
    $1.61
    downward going graph

    3.47%

    Downside

    11.81%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.16
    $14.10
    downward going graph

    19.44%

    Downside

    879.17%

    Upside

    downward going graph

Purple Biotech share price movements today

Previous Close
$1.54
Open
$1.51
Volume
802.4K
Market Cap
$2.5M
Day's Low - High
$1.39 - $1.61
52 Week Low - High
$1.16 - $14.10

Purple Biotech Historical Returns

1 Month Return
-2.83 %
3 Month Return
-9.12 %
1 Year Return
-73.5 %
3 Year Return
-99.3 %
5 Year Return
-99.84 %

Purple Biotech Stock Fundamentals & Key Indicators

Check Purple Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.5M

EPS (TTM)

-5.73

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-111.13%

Purple Biotech vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Purple Biotech with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$2.5M-99.84%NA0.00%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Purple Biotech Stock including INR - Dollar returns

The Purple Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Purple Biotech investment value today

Current value as on today

₹26,881

Returns

-₹73,119

(-73.12%)

Returns from Purple Biotech Stock

-₹75,300 (-75.3%)

Dollar Impact

₹2,181 (+2.18%)

Analyst Recommendation on Purple Biotech Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Purple Biotech. Average target price of $17

Indian Investors' Interest in Purple Biotech Stock

Investment in Purple Biotech Shares on INDmoney has grown by 1212.50% in the last 30 days, indicating increased investment activity.

Time period: to

Change:1212.50% versus previous 30 day period

Search interest for Purple Biotech Stock has increased by 833% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:833% versus previous 30 day period

Purple Biotech Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
0
0
0
-
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-2
0
0
0
-1
-1
-23
0
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Purple Biotech Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
1
1
1
0
0
0
-
-
Gross Profit
0
1
0
0
0
0
0
0
0
Operating Income
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-12
-5
-5
-28
-18
-21
-19
-7
-26
Net Profit Margin
-12177.00%
-520.00%
-585.00%
-2819.55%
5745.00%
2381.10%
-10153.01%
0.00%
0.00%

Global Institutional Holdings in Purple Biotech

Funds
Holdings
Virtu Financial LLC
0.53%
GAMMA Investing LLC
0.01%
Royal Bank of Canada
0%
Northwestern Mutual Wealth Management Co
0%
Global Retirement Partners, LLC.
0%

Purple Biotech News & Key Events

  • img

    Today's Timeline - 02 September

    Wed, 05:03 PM

    -

    Purple Biotech receives U.S. patent allowance for CAPTN-3 platform, enhancing its intellectual property for multispecific antibodies.

Insights on Purple Biotech

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 44.3% return, outperforming this stock by 143.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 585.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PPBT stock has moved down by -16.3%

About Purple Biotech

Purple Biotech Ltd., a clinical-stage biotechnology firm based in Rehovot, Israel, is dedicated to pioneering treatments that help cancer patients, particularly in the United States, overcome tumor immune evasion and drug resistance. Its pipeline features two primary oncology assets: CM24: A monoclonal antibody designed to block carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1). This candidate is undergoing Phase 1b/2 clinical trials, where it is being evaluated as a combination therapy with anti-PD-1 checkpoint inhibitors for non-small cell lung cancer and pancreatic cancer. NT219: A small molecule compound that targets insulin receptor substrate 1 and 2 (IRS1/2) as well as signal transducer and activator of transcription (STAT) pathways. NT219 is currently in Phase 1/2 clinical studies for the treatment of recurrent or metastatic solid tumors and squamous cell carcinoma of the head and neck. The company was formerly known as Kitov Pharma Ltd until its rebranding to Purple Biotech Ltd. in December 2020.
OrganisationPurple Biotech
Headquarters4 Oppenheimer Street, Rehovot, TA, 7670104, IL
IndustryBiotechnology
CEOGil Efron
E-voting on sharesClick here to vote

Key Management of Purple Biotech

Name

Title

Dr. Michael Schickler Ph.D.

Head of Clinical & Regulatory Affairs

Mr. Shai Lankry CPA, M.B.A.

Chief Financial Officer

FAQs

What is Purple Biotech share price today?

Purple Biotech share price today is $1.44 as on at the close of the market. Purple Biotech share today touched a day high of $1.61 and a low of $1.39.

What is the 52 week high and 52 week low for Purple Biotech share?

Purple Biotech share touched a 52 week high of $14.10 on and a 52 week low of $1.16 on . Purple Biotech stock price today i.e. is closed at $1.44,which is 89.79% down from its 52 week high and 24.14% up from its 52 week low.

What is Purple Biotech's market capitalisation today?

Purple Biotech market capitalisation is $0.00T as on .

How to invest in Purple Biotech Stock (PPBT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Purple Biotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Purple Biotech Shares that will get you 1.0417 shares as per Purple Biotech share price of $1.44 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Purple Biotech Stock (PPBT) from India?

Indian investors can start investing in Purple Biotech (PPBT) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Purple Biotech stock (as per the Rupee-Dollar exchange rate as on ). Based on Purple Biotech share’s latest price of $1.44 as on September 19, 2026 at 8:45 am IST, you will get 6.9444 shares of Purple Biotech. Learn more about fractional shares .

What are the returns that Purple Biotech has given to Indian investors in the last 5 years?

Purple Biotech stock has given -99.84% share price returns and 30.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?